Curanex Pharmaceuticals Faces Two Securities Class Actions Over IPO
Curanex Pharmaceuticals is defending two putative securities class actions alleging misstatements and omissions in documents for its August 2025 IPO.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.